BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34980610)

  • 1. Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease.
    Marceglia S; Conti C; Svanidze O; Foffani G; Lozano AM; Moro E; Volkmann J; Arlotti M; Rossi L; Priori A
    BMJ Open; 2022 Jan; 12(1):e049955. PubMed ID: 34980610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson's disease.
    He S; Baig F; Merla A; Torrecillos F; Perera A; Wiest C; Debarros J; Benjaber M; Hart MG; Ricciardi L; Morgante F; Hasegawa H; Samuel M; Edwards M; Denison T; Pogosyan A; Ashkan K; Pereira E; Tan H
    Brain; 2023 Dec; 146(12):5015-5030. PubMed ID: 37433037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive deep brain stimulation as advanced Parkinson's disease treatment (ADAPT study): protocol for a pseudo-randomised clinical study.
    Piña-Fuentes D; Beudel M; Little S; Brown P; Oterdoom DLM; van Dijk JMC
    BMJ Open; 2019 Jun; 9(6):e029652. PubMed ID: 31201193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of adaptive Deep Brain Stimulation in Parkinson's disease.
    Piña-Fuentes D; van Dijk JMC; van Zijl JC; Moes HR; van Laar T; Oterdoom DLM; Little S; Brown P; Beudel M
    Brain Stimul; 2020; 13(6):1507-1516. PubMed ID: 32738409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations.
    Priori A; Foffani G; Rossi L; Marceglia S
    Exp Neurol; 2013 Jul; 245():77-86. PubMed ID: 23022916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive deep brain stimulation for Parkinson's disease: looking back at the past decade on motor outcomes.
    An Q; Yin Z; Ma R; Fan H; Xu Y; Gan Y; Gao Y; Meng F; Yang A; Jiang Y; Zhu G; Zhang J
    J Neurol; 2023 Mar; 270(3):1371-1387. PubMed ID: 36471098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-Off and Proportional Closed-Loop Adaptive Deep Brain Stimulation Reduces Motor Symptoms in Freely Moving Hemiparkinsonian Rats.
    Evers J; Orłowski J; Jahns H; Lowery MM
    Neuromodulation; 2024 Apr; 27(3):476-488. PubMed ID: 37245140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral adaptive deep brain stimulation is effective in Parkinson's disease.
    Little S; Beudel M; Zrinzo L; Foltynie T; Limousin P; Hariz M; Neal S; Cheeran B; Cagnan H; Gratwicke J; Aziz TZ; Pogosyan A; Brown P
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):717-21. PubMed ID: 26424898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus deep brain stimulation driven by primary motor cortex γ2 activity in parkinsonian monkeys.
    Darbin O; Hatanaka N; Takara S; Kaneko N; Chiken S; Naritoku D; Martino A; Nambu A
    Sci Rep; 2022 Apr; 12(1):6493. PubMed ID: 35444245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
    Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
    Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single threshold adaptive deep brain stimulation in Parkinson's disease depends on parameter selection, movement state and controllability of subthalamic beta activity.
    Busch JL; Kaplan J; Habets JGV; Feldmann LK; Roediger J; Köhler RM; Merk T; Faust K; Schneider GH; Bergman H; Neumann WJ; Kühn AA
    Brain Stimul; 2024; 17(1):125-133. PubMed ID: 38266773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between Electrical Energy Delivered by Deep Brain Stimulation and Levodopa-Induced Dyskinesias in Parkinson's Disease: A Retrospective Preliminary Analysis.
    Prenassi M; Arlotti M; Borellini L; Bocci T; Cogiamanian F; Locatelli M; Rampini P; Barbieri S; Priori A; Marceglia S
    Front Neurol; 2021; 12():643841. PubMed ID: 34135846
    [No Abstract]   [Full Text] [Related]  

  • 13. Adaptive deep brain stimulation in Parkinson's disease.
    Beudel M; Brown P
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S123-6. PubMed ID: 26411502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bocci T; Prenassi M; Arlotti M; Cogiamanian FM; Borellini L; Moro E; Lozano AM; Volkmann J; Barbieri S; Priori A; Marceglia S
    NPJ Parkinsons Dis; 2021 Sep; 7(1):88. PubMed ID: 34584095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive deep brain stimulation in advanced Parkinson disease.
    Little S; Pogosyan A; Neal S; Zavala B; Zrinzo L; Hariz M; Foltynie T; Limousin P; Ashkan K; FitzGerald J; Green AL; Aziz TZ; Brown P
    Ann Neurol; 2013 Sep; 74(3):449-57. PubMed ID: 23852650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable- versus constant-frequency deep-brain stimulation in patients with advanced Parkinson's disease: study protocol for a randomized controlled trial.
    Jia F; Zhang J; Wang H; Liang Z; Liu W; Wang X; Liu Y; Guo Y; Ling Z; Cai X; Wu X; Wu J; Lv W; Xu X; Zhang W; Li L
    Trials; 2019 Dec; 20(1):749. PubMed ID: 31856908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.
    Charles D; Konrad PE; Neimat JS; Molinari AL; Tramontana MG; Finder SG; Gill CE; Bliton MJ; Kao C; Phibbs FT; Hedera P; Salomon RM; Cannard KR; Wang L; Song Y; Davis TL
    Parkinsonism Relat Disord; 2014 Jul; 20(7):731-7. PubMed ID: 24768120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.